Navigation Links
ACell's CEO to Present at Rodman & Renshaw's 2009 Annual Global Investment Conference
Date:9/2/2009

COLUMBIA, Md., Sept. 2 /PRNewswire/ -- ACell, Inc. is announcing its participation at Rodman & Renshaw's 2009 Annual Global Investment Conference.

The conference will be held September 9, 2009 through September 11, 2009 at the New York Palace Hotel in New York City. James DeFrancesco, Chief Executive Officer and President, is scheduled to make an investor presentation on September 11th beginning at 9:10 AM (EDT) in the Hubbard Room. The presentation is expected to take approximately 25 minutes. Investors and strategic partners interested in ACell's proprietary technology are encouraged to contact the company for private one on one discussion while attending the conference.

Mr. DeFrancesco's presentation will provide an update on ACell's regenerative medicine technology and share clinical results of recently completed cases. ACell introduced its wound care devices utilizing a major marketing partner last January. Now, with the recent release of several new extracellular matrix (ECM) surgical devices, ACell is targeting the US plastic surgery, hernia and trauma markets. Several orthopedic products are scheduled for release next year. The company has recently received significant media coverage for the involvement of its MatriStem((R)) MicroMatrix(TM) in re-growing severed fingertips.

ACell Inc.

ACell is a private company with multiple US and international patents for its proprietary UBM (Urinary Bladder Matrix) ECM technology. ACell's advanced bio-scaffold devices consist of an intact epithelial basement membrane, naturally derived bioactive molecules and multiple collagen types known to assist the body in the regeneration of new tissues. Commercially branded as MatriStem((R)), UBM can be used in a broad range of regenerative medicine applications. ACell currently has five FDA 510(k) clearances addressing wound care and various surgical indications.

www.acell.com


'/>"/>
SOURCE ACell, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Transcept Pharmaceuticals to Present at the BioCentury Thomson Reuters Newsmakers in the Biotech Industry Conference on September 16, 2009
2. BioMarin to Present at the Baird Healthcare Conference
3. Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September
4. NeurogesX to Present at Upcoming Fall Conferences
5. Repligen to Present at the Rodman & Renshaw 11th Annual Healthcare Conference Wednesday, September 9th, 2:25 p.m. EDT
6. Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting
7. Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
8. Express Scripts to Present at Investor Conferences
9. ERT to Present at Bairds 2009 Health Care Conference on September 9, 2009
10. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
11. PAREXEL International to Present at Robert Baird 2009 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Island, NY (PRWEB) , ... February 24, 2017 , ... ... rate. Founded in late 2014, FireflySci had the goal of bringing their powerful ... that goal continues to shape the path that FireflySci is going on as they ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... leading digital health company, and Digital Noema ... and remote patient monitoring, announce they are partnering ... DN Telehealth maximizes collaboration compatibility for ... consultations beyond a physical clinical setting to include ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring ... home or in healthcare facilities during periods of rest. A lightweight, non-invasive monitor ...
Breaking Biology Technology:
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
(Date:2/7/2017)... LONG BEACH, New York , February 7, 2017 ... formerly known as ID Global Solutions Corporation [OTC: IDGS], ... identification, identity management and electronic transaction processing services, is ... a reorganization of the Company. Effective January ... Chairman of the Board of Directors, CEO and President. ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
Breaking Biology News(10 mins):